Published in PLoS One on January 31, 2013
Apoptotic-like Leishmania exploit the host's autophagy machinery to reduce T-cell-mediated parasite elimination. Autophagy (2015) 0.82
Potent In Vitro Antiproliferative Synergism of Combinations of Ergosterol Biosynthesis Inhibitors against Leishmania amazonensis. Antimicrob Agents Chemother (2015) 0.80
Genetic profiling of the isoprenoid and sterol biosynthesis pathway genes of Trypanosoma cruzi. PLoS One (2014) 0.79
Soulamarin isolated from Calophyllum brasiliense (Clusiaceae) induces plasma membrane permeabilization of Trypanosoma cruzi and mytochondrial dysfunction. PLoS Negl Trop Dis (2013) 0.77
Trypanosoma cruzi cell death induced by the Morita-Baylis-Hillman adduct 3-Hydroxy-2-methylene-3-(4-nitrophenylpropanenitrile). PLoS One (2014) 0.76
The Oral Antimalarial Drug Tafenoquine Shows Activity against Trypanosoma brucei. Antimicrob Agents Chemother (2015) 0.76
Trypanosoma cruzi Intracellular Amastigotes Isolated by Nitrogen Decompression Are Capable of Endocytosis and Cargo Storage in Reservosomes. PLoS One (2015) 0.75
Ketanserin, an antidepressant, exerts its antileishmanial action via inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) enzyme of Leishmania donovani. Parasitol Res (2014) 0.75
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ (2008) 10.45
Chagas disease. Lancet (2010) 10.25
Mitochondria supply membranes for autophagosome biogenesis during starvation. Cell (2010) 8.29
Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell (2008) 7.61
Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev (1999) 5.51
Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol (2004) 5.31
Cell death by necrosis: towards a molecular definition. Trends Biochem Sci (2006) 4.67
Monitoring of relative mitochondrial membrane potential in living cells by fluorescence microscopy. J Cell Biol (1981) 3.97
The discovery and development of HMG-CoA reductase inhibitors. J Lipid Res (1992) 3.02
Epidemiology, control and surveillance of Chagas disease: 100 years after its discovery. Mem Inst Oswaldo Cruz (2009) 2.87
The mitochondrial inner membrane protein mitofilin controls cristae morphology. Mol Biol Cell (2005) 2.53
Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches. Acta Trop (2009) 2.37
Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration features. Cell Death Differ (2009) 2.33
Chemical and physiological characterization of fluo-4 Ca(2+)-indicator dyes. Cell Calcium (2000) 2.32
Rapid isolation of DNA from trypanosomatid protozoa using a simple 'mini-prep' procedure. Mol Biochem Parasitol (1993) 2.19
In vitro and in vivo activities of ravuconazole on Trypanosoma cruzi, the causative agent of Chagas disease. Int J Antimicrob Agents (2003) 2.18
Specific aspartyl and calpain proteases are required for neurodegeneration in C. elegans. Nature (2002) 1.97
Regulation of apoptosis-associated lysosomal membrane permeabilization. Apoptosis (2010) 1.92
Activities of the triazole derivative SCH 56592 (posaconazole) against drug-resistant strains of the protozoan parasite Trypanosoma (Schizotrypanum) cruzi in immunocompetent and immunosuppressed murine hosts. Antimicrob Agents Chemother (2000) 1.87
Fatty acid and sterol metabolism: potential antimicrobial targets in apicomplexan and trypanosomatid parasitic protozoa. Mol Biochem Parasitol (2003) 1.87
Trypanocidal drugs: mechanisms, resistance and new targets. Expert Rev Mol Med (2009) 1.84
Ergosterol biosynthesis and drug development for Chagas disease. Mem Inst Oswaldo Cruz (2009) 1.84
Cure of short- and long-term experimental Chagas' disease using D0870. Science (1996) 1.75
Structural insights into inhibition of sterol 14alpha-demethylase in the human pathogen Trypanosoma cruzi. J Biol Chem (2010) 1.71
Antiproliferative effects and mechanism of action of SCH 56592 against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies. Antimicrob Agents Chemother (1998) 1.65
Intracellular Ca2+ storage in acidocalcisomes of Trypanosoma cruzi. Biochem J (1995) 1.54
Link between mitochondria and NADPH oxidase 1 isozyme for the sustained production of reactive oxygen species and cell death. J Biol Chem (2006) 1.47
Biological aspects of the Dm 28c clone of Trypanosoma cruzi after metacyclogenesis in chemically defined media. Mem Inst Oswaldo Cruz (1989) 1.47
Modification of the sterol composition of Trypanosoma (Schizotrypanum) cruzi epimastigotes by delta 24(25)-sterol methyl transferase inhibitors and their combinations with ketoconazole. Mol Biochem Parasitol (1995) 1.44
Mevinolin (lovastatin) potentiates the antiproliferative effects of ketoconazole and terbinafine against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies. Antimicrob Agents Chemother (1993) 1.43
Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates. Prog Neurobiol (2000) 1.43
Calcium regulation in protozoan parasites. Curr Opin Microbiol (2003) 1.41
Ultrastructural alterations induced by two ergosterol biosynthesis inhibitors, ketoconazole and terbinafine, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi. Antimicrob Agents Chemother (1990) 1.39
Apoptosis in a unicellular eukaryote (Trypanosoma cruzi): implications for the evolutionary origin and role of programmed cell death in the control of cell proliferation, differentiation and survival. Cell Death Differ (1995) 1.37
Programmed cell deaths. Apoptosis and alternative deathstyles. Eur J Biochem (2004) 1.36
Antiproliferative synergism of the allylamine SF 86-327 and ketoconazole on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi. Antimicrob Agents Chemother (1988) 1.33
Sterol Biosynthesis Pathway as Target for Anti-trypanosomatid Drugs. Interdiscip Perspect Infect Dis (2009) 1.32
Autophagy is involved in nutritional stress response and differentiation in Trypanosoma cruzi. J Biol Chem (2007) 1.31
Ca2+-dependent proteases in ischemic neuronal death: a conserved 'calpain-cathepsin cascade' from nematodes to primates. Cell Calcium (2004) 1.30
Ketoconazole inhibition of intracellular multiplication of Trypanosoma cruzi and protection of mice against lethal infection with the organism. J Infect Dis (1984) 1.27
Parasitological cure of acute and chronic experimental Chagas disease using the long-acting experimental triazole TAK-187. Activity against drug-resistant Trypanosoma cruzi strains. Int J Antimicrob Agents (2003) 1.27
Protozoan parasites: programmed cell death as a mechanism of parasitism. Trends Parasitol (2007) 1.24
Alteration of lipid order profile and permeability of plasma membranes from Trypanosoma cruzi epimastigotes grown in the presence of ketoconazole. Mol Biochem Parasitol (1988) 1.23
Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP. Cancer Res (1998) 1.19
Endocytosis of gold-labeled proteins and LDL by Trypanosoma cruzi. Parasitol Res (1991) 1.15
Redundant cell death mechanisms as relics and backups. Cell Death Differ (2005) 1.12
Electron microscopy and cytochemistry analysis of the endocytic pathway of pathogenic protozoa. Prog Histochem Cytochem (2009) 1.12
Metacaspases of Trypanosoma cruzi: possible candidates for programmed cell death mediators. Mol Biochem Parasitol (2005) 1.10
Comparison of lanosterol-14 alpha-demethylase (CYP51) of human and Candida albicans for inhibition by different antifungal azoles. Toxicology (2006) 1.09
Effects of ketoconazole on sterol biosynthesis by Trypanosoma cruzi epimastigotes. Biochem Biophys Res Commun (1986) 1.09
Ca2+-induced increased lipid packing and domain formation in submitochondrial particles. A possible early step in the mechanism of Ca2+-stimulated generation of reactive oxygen species by the respiratory chain. Biochemistry (1999) 1.09
Antiproliferative effects and mechanism of action of ICI 195,739, a novel bis-triazole derivative, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi. Antimicrob Agents Chemother (1991) 1.08
Ultrastructural alterations induced by ICI 195,739, a bis-triazole derivative with strong antiproliferative action against Trypanosoma (Schizotrypanum) cruzi. Antimicrob Agents Chemother (1991) 1.06
Sterol methenyl transferase inhibitors alter the ultrastructure and function of the Leishmania amazonensis mitochondrion leading to potent growth inhibition. Protist (2007) 1.06
Trypanosoma cruzi epimastigote endocytic pathway: cargo enters the cytostome and passes through an early endosomal network before storage in reservosomes. Eur J Cell Biol (2000) 1.05
A necrotic cell death model in a protist. Cell Death Differ (2006) 1.05
Autophagy and related processes in trypanosomatids: insights from genomic and bioinformatic analyses. Autophagy (2006) 1.05
An experimental and clinical assay with ketoconazole in the treatment of Chagas disease. Mem Inst Oswaldo Cruz (1993) 1.05
Sterol 14-demethylase inhibitors for Trypanosoma cruzi infections. Adv Exp Med Biol (2008) 1.05
Inhibition of isoprenoid biosynthesis induces apoptosis in human promyelocytic HL-60 cells. Biochem Biophys Res Commun (1994) 1.04
Sterol composition and biosynthesis in Trypanosoma cruzi amastigotes. Mol Biochem Parasitol (1999) 1.04
All Trypanosoma cruzi developmental forms present lysosome-related organelles. Histochem Cell Biol (2008) 1.03
3-Hydroxy-3-methyl-glutaryl-CoA reductase in Trypanosoma (Schizotrypanum) cruzi: subcellular localization and kinetic properties. Arch Biochem Biophys (1998) 1.03
Mechanism of Trypanosoma cruzi death induced by Cratylia mollis seed lectin. J Bioenerg Biomembr (2010) 1.03
In-vitro antiproliferative effects and mechanism of action of the bis-triazole D0870 and its S(-) enantiomer against Trypanosoma cruzi. J Antimicrob Chemother (1998) 1.00
Mitochondrial permeability transition and swelling can occur reversibly without inducing cell death in intact human cells. Exp Cell Res (1999) 0.99
Anti-proliferative synergy of lysophospholipid analogues and ketoconazole against Trypanosoma cruzi (Kinetoplastida: Trypanosomatidae): cellular and ultrastructural analysis. J Antimicrob Chemother (2005) 0.99
Subcellular proteomics of Trypanosoma cruzi reservosomes. Proteomics (2009) 0.97
In vitro antiproliferative effects and mechanism of action of the new triazole derivative UR-9825 against the protozoan parasite Trypanosoma (Schizotrypanum) cruzi. Antimicrob Agents Chemother (2000) 0.96
Lovastatin induces apoptosis in malignant mesothelioma cells. Am J Respir Crit Care Med (1998) 0.95
Failure of ketoconazole to cure chronic murine Chagas' disease. J Infect Dis (1988) 0.95
Reservosomes: multipurpose organelles? Parasitol Res (2006) 0.94
Cytoplasmic organelles of trypanosomatids: a cytochemical and stereological study. J Submicrosc Cytol Pathol (1988) 0.94
Electron microscopy in antiparasitic chemotherapy: a (close) view to a kill. Curr Drug Targets (2009) 0.93
The sterol composition of Trypanosoma cruzi changes after growth in different culture media and results in different sensitivity to digitonin-permeabilization. J Eukaryot Microbiol (2001) 0.93
Differential inhibition of human CYP3A4 and Candida albicans CYP51 with azole antifungal agents. Chem Biol Interact (2000) 0.93
Vaccine development against Trypanosoma cruzi and Leishmania species in the post-genomic era. Infect Genet Evol (2009) 0.92
Necrotic cell death: From reversible mitochondrial uncoupling to irreversible lysosomal permeabilization. Exp Cell Res (2008) 0.92
Bisphosphonates as inhibitors of Trypanosoma cruzi hexokinase: kinetic and metabolic studies. J Biol Chem (2007) 0.92
Perspectives of vaccination in Chagas disease revisited. Mem Inst Oswaldo Cruz (2009) 0.91
Mitochondrial localization of the mevalonate pathway enzyme 3-Hydroxy-3-methyl-glutaryl-CoA reductase in the Trypanosomatidae. Mol Biol Cell (2003) 0.91
Diverse effects on mitochondrial and nuclear functions elicited by drugs and genetic knockdowns in bloodstream stage Trypanosoma brucei. PLoS Negl Trop Dis (2010) 0.90
Lovastatin-induced apoptosis in prostate stromal cells. J Clin Endocrinol Metab (1997) 0.90
Altered lipid composition and enzyme activities of plasma membranes from Trypanosoma (Schizotrypanum) cruzi epimastigotes grown in the presence of sterol biosynthesis inhibitors. Biochem Pharmacol (1997) 0.89
Mitochondrial disruption and DNA fragmentation in Trypanosoma cruzi induced by naphthoimidazoles synthesized from beta-lapachone. Parasitol Res (2007) 0.87
Effects of squalene synthase inhibitors on the growth and ultrastructure of Trypanosoma cruzi. Int J Antimicrob Agents (2004) 0.87
Antagonic activities of Trypanosoma cruzi metacaspases affect the balance between cell proliferation, death and differentiation. Cell Death Differ (2012) 0.86
Molecular characterization of the Trypanosoma cruzi specific RNA binding protein TcRBP40 and its associated mRNAs. Biochem Biophys Res Commun (2012) 0.85
The pharmacological inhibition of sterol biosynthesis in Leishmania is counteracted by enhancement of LDL endocytosis. Acta Trop (2011) 0.84
Ultrastructural alterations in Trypanosoma (Schizotrypanum) cruzi induced by Delta(24(25)) sterol methyl transferase inhibitors and their combinations with ketoconazole. Int J Antimicrob Agents (1997) 0.82
Lovastatin inhibits proliferation and differentiation and causes apoptosis in lipopolysaccharide-stimulated murine B cells. Biochem Biophys Res Commun (1995) 0.82
The effect of Bulgarian propolis against Trypanosoma cruzi and during its interaction with host cells. Mem Inst Oswaldo Cruz (2006) 0.81
Inhibition of Trypanosoma cruzi growth and sterol biosynthesis by lovastatin. Biochem Biophys Res Commun (1990) 0.80
Kinetic properties and inhibition of Trypanosoma cruzi 3-hydroxy-3-methylglutaryl CoA reductase. FEBS Lett (2002) 0.79
Ketoconazole-induced JNK phosphorylation and subsequent cell death via apoptosis in human osteosarcoma cells. Toxicol In Vitro (2009) 0.78
Effects of inhibitors of Delta24(25)-sterol methyl transferase on the ultrastructure of epimastigotes of Trypanosoma cruzi. Microsc Microanal (2005) 0.77
Ketoconazole-induced apoptosis through P53-dependent pathway in human colorectal and hepatocellular carcinoma cell lines. Toxicol Appl Pharmacol (1998) 0.77
Dengue virus infections: comparison of methods for diagnosing the acute disease. J Clin Virol (2005) 1.29
Evidence of P-body-like structures in Trypanosoma cruzi. Biochem Biophys Res Commun (2007) 1.18
Quantitative proteomics of Trypanosoma cruzi during metacyclogenesis. Proteomics (2012) 1.03
Evidence for the co-circulation of dengue virus type 3 genotypes III and V in the Northern region of Brazil during the 2002-2004 epidemics. Mem Inst Oswaldo Cruz (2008) 0.96
Predicting the proteins of Angomonas deanei, Strigomonas culicis and their respective endosymbionts reveals new aspects of the trypanosomatidae family. PLoS One (2013) 0.95
Anopheles albitarsis embryogenesis: morphological identification of major events. Mem Inst Oswaldo Cruz (2002) 0.94
Viability study of a multiplex diagnostic platform for Chagas disease. Mem Inst Oswaldo Cruz (2009) 0.93
Characteristics of biofilm formation by Candida tropicalis and antifungal resistance. FEMS Yeast Res (2008) 0.91
Small-subunit rRNA processome proteins are translationally regulated during differentiation of Trypanosoma cruzi. Eukaryot Cell (2006) 0.90
A novel expression profile of the Loxosceles intermedia spider venomous gland revealed by transcriptome analysis. Mol Biosyst (2010) 0.89
Stage-specific gene expression during Trypanosoma cruzi metacyclogenesis. Genet Mol Res (2003) 0.87
Crystal structure of chagasin, the endogenous cysteine-protease inhibitor from Trypanosoma cruzi. J Struct Biol (2006) 0.87
Knockout of the gene encoding the kinetoplast-associated protein 3 (KAP3) in Trypanosoma cruzi: effect on kinetoplast organization, cell proliferation and differentiation. Mol Biochem Parasitol (2010) 0.86
Association between vitamin D receptor gene polymorphisms and susceptibility to chronic kidney disease and periodontitis. Blood Purif (2007) 0.86
Use of the EIE-recombinant-Chagas-biomanguinhos kit to monitor cure of human Chagas' disease. J Clin Lab Anal (2002) 0.85
Patterns of exochorion ornaments on eggs of seven South American species of Lutzomyia sand flies (Diptera: Psychodidae). J Med Entomol (2004) 0.84
Identification and subcellular localization of TcHIP, a putative Golgi zDHHC palmitoyl transferase of Trypanosoma cruzi. Exp Parasitol (2013) 0.83
In vitro effects of citral on trypanosoma cruzi metacyclogenesis. Mem Inst Oswaldo Cruz (2010) 0.83
Hepatitis C virus quantification in serum and saliva of HCV-infected patients. Mem Inst Oswaldo Cruz (2012) 0.82
Trypanosoma cruzi heparin-binding proteins and the nature of the host cell heparan sulfate-binding domain. Microb Pathog (2007) 0.81
Stage-regulated GFP Expression in Trypanosoma cruzi: applications from host-parasite interactions to drug screening. PLoS One (2013) 0.80
Actin expression in trypanosomatids (Euglenozoa: Kinetoplastea). Mem Inst Oswaldo Cruz (2013) 0.80
Recombinant antigen production for assays of intradermoreaction for diagnosis and surveillance of tuberculosis. J Biotechnol (2011) 0.80
In vitro formation of capillary tubules from human umbilical cord blood cells with perspectives for therapeutic application. Rev Bras Cir Cardiovasc (2009) 0.80
Humoral and cellular immune responses in BALB/c and C57BL/6 mice immunized with cytoplasmic (CRA) and flagellar (FRA) recombinant repetitive antigens, in acute experimental Trypanosoma cruzi infection. Parasitol Res (2005) 0.80
The zinc finger protein TcZFP2 binds target mRNAs enriched during Trypanosoma cruzi metacyclogenesis. Mem Inst Oswaldo Cruz (2012) 0.80
Expression and subcellular localization of kinetoplast-associated proteins in the different developmental stages of Trypanosoma cruzi. BMC Microbiol (2009) 0.79
Biological activity of yangambin on the postembryonic development of Chrysomya megacephala (Diptera: Calliphoridae). J Med Entomol (2007) 0.79
Fibrosis and hypertrophy induced by Trypanosoma cruzi in a three-dimensional cardiomyocyte-culture system. J Infect Dis (2008) 0.79
Analysis of IL1 gene polymorphisms and transcript levels in periodontal and chronic kidney disease. Cytokine (2012) 0.79
An isoniazid analogue promotes Mycobacterium tuberculosis-nanoparticle interactions and enhances bacterial killing by macrophages. Antimicrob Agents Chemother (2012) 0.78
Identification, molecular and functional characterization of calmodulin gene of Phytomonas serpens 15T that shares high similarity with its pathogenic counterparts Trypanosoma cruzi. Protein J (2011) 0.77
Characterization of the Trypanosoma cruzi ortholog of the SBDS protein reveals an intrinsically disordered extended C-terminal region showing RNA-interacting activity. Biochimie (2008) 0.77
Initial characterization of a recombinant kynureninase from Trypanosoma cruzi identified from an EST database. Gene (2009) 0.76
Subcellular localization of an intracellular serine protease of 68 kDa in Leishmania (Leishmania) amazonensis promastigotes. Mem Inst Oswaldo Cruz (2005) 0.76
Endocytosis in Trypanosoma cruzi (Euglenozoa: Kinetoplastea) epimastigotes: visualization of ingested transferrin-gold nanoparticle complexes by confocal laser microscopy. J Microbiol Methods (2012) 0.75
Crystallization and preliminary X-ray diffraction analysis of Q4DV70 from Trypanosoma cruzi, a hypothetical protein with a putative thioredoxin domain. Acta Crystallogr Sect F Struct Biol Cryst Commun (2009) 0.75
Recently differentiated epimastigotes from Trypanosoma cruzi are infective to the mammalian host. Mol Microbiol (2017) 0.75